Moneycontrol PRO
you are here: HomeNewsIndia

XBB.1.16 variant 'new kid on the block', could be driving recent rise in Covid cases: Randeep Guleria

New variants will keep coming as the virus keeps on mutating over the time and the XBB 1.16 is sort of a "new kid on the block", Guleria said.

March 22, 2023 / 07:07 PM IST
India recorded 1,134 new coronavirus cases, the highest in 138 days, while the active cases increased to 7,026, according to the Union Health Ministry data updated on Wednesday. (Representative image)

India recorded 1,134 new coronavirus cases, the highest in 138 days, while the active cases increased to 7,026, according to the Union Health Ministry data updated on Wednesday. (Representative image)

As India witnessed the highest number of Covid cases in over four months, former AIIMS director Dr Randeep Guleria on Wednesday said the new XBB.1.16 variant could be driving the recent rise but emphasised there was no need for panic as long it does not cause severe illness and deaths.

New variants will keep coming as the virus keeps on mutating over the time and the XBB 1.16 is sort of a "new kid on the block", Guleria told PTI in an interview.

"... As long as they don't lead to severe illness, hospitalisation and deaths, it is alright because it helps in giving some degree of immunity to the population if they have mild illness," the renowned pulmonologist, who was part of the national Covid task force, said.

His comments come on a day when Prime Minister Narendra Modi held a high-level meeting to review the Covid situation and also took stock of the public health preparedness.

India recorded 1,134 new coronavirus cases, the highest in 138 days, while the active cases increased to 7,026, according to the Union Health Ministry data updated on Wednesday.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The death toll has climbed to 5,30,813 with five deaths.

According to Dr Guleria, the virus evolves over time, and this happens both with Covid and influenza, and this is what is called an antigenic drift.

It will gradually evolve, mutate a little bit and new variants will emerge, he added.

"If we remember when we had the Covid outbreak, it started off with Alpha, Beta, Gamma Delta and Omicron variants.

"So the virus kept on changing. Luckily, if we look at what has happened in the last one year, we have got variants which are basically sub-lineages of Omicron only. So it seems the virus has stabilized a little bit, it is not changing as rapidly as it was in the past," Dr Guleria said.

On whether XBB 1.16 has the potential to drive a fresh wave of cases in the next few days, he said, "You may see a surge in number of cases" but then they may be underreported as initially people were very concerned and would get themselves tested.

"Now even if they have flu-like symptoms, most people don't get themselves tested. Some use the rapid antigen test, and even if they are positive they do not report it. So the number we are actually reporting may be less than the actual number in the community." Dr Guleria advised that those who test positive must report the data because that helps policy makers and government to actually to know the number of cases and take a decision and plan a strategy.

"So even if we see surge, there is no need to worry, as long it does not translate into hospitalization and deaths it is alright," he said.

He said there is a need for active surveillance both at hospital and community levels to find out whether there is an increase in number of cases and hospital admissions so that containment strategies and other public health measures can be implemented on time.

PTI
first published: Mar 22, 2023 07:02 pm